feed,title,long_url,short_url
Benzinga,"Seacoast Banking Corporation of Florida to Announce Third Quarter Earnings Results October 27, 2020",https://www.benzinga.com/pressreleases/20/10/g17789284/seacoast-banking-corporation-of-florida-to-announce-third-quarter-earnings-results-october-27-2020,https://j.mp/36uXBY6
Benzinga,Nkarta Announces Leadership Changes,https://www.benzinga.com/pressreleases/20/10/g17789283/nkarta-announces-leadership-changes,https://j.mp/3nn8uB2
Benzinga,Kimball International Announces Executive Changes,https://www.benzinga.com/pressreleases/20/10/g17789264/kimball-international-announces-executive-changes,https://j.mp/34qLpF8
Benzinga,Y-mAbs Provides Regulatory Update on Omburtamab for the Treatment of Patients with Neuroblastoma,https://www.benzinga.com/pressreleases/20/10/g17789262/y-mabs-provides-regulatory-update-on-omburtamab-for-the-treatment-of-patients-with-neuroblastoma,https://j.mp/30ypsmw
Benzinga,H/Cell Energy Announces Restructuring Changes,https://www.benzinga.com/pressreleases/20/10/g17789261/hcell-energy-announces-restructuring-changes,https://j.mp/3nn8qkM
Benzinga,Theratechnologies to Announce Financial Results for Third Quarter 2020,https://www.benzinga.com/pressreleases/20/10/g17789260/theratechnologies-to-announce-financial-results-for-third-quarter-2020,https://j.mp/3ljcZuy
Benzinga,Pulmonx Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares,https://www.benzinga.com/pressreleases/20/10/g17789259/pulmonx-announces-closing-of-initial-public-offering-and-full-exercise-of-the-underwriters-option-,https://j.mp/36zgzg9
Benzinga,"Applied BioMath, LLC Announces Two-Year Strategic Partnership with Xilio Therapeutics",https://www.benzinga.com/pressreleases/20/10/n17789279/applied-biomath-llc-announces-two-year-strategic-partnership-with-xilio-therapeutics,https://j.mp/2Gm0gJ4
Benzinga,"Recharge Acquisition Corp. Announces Closing of $200,000,000 Initial Public Offering",https://www.benzinga.com/pressreleases/20/10/g17789226/recharge-acquisition-corp-announces-closing-of-200-000-000-initial-public-offering,https://j.mp/2I0PVmb
Benzinga,Duke Realty Corporation Schedules Third Quarter 2020 Earnings Release and Conference Call,https://www.benzinga.com/pressreleases/20/10/g17789225/duke-realty-corporation-schedules-third-quarter-2020-earnings-release-and-conference-call,https://j.mp/3cZU9G2
Benzinga,Supernus Pharmaceuticals Appoints James Kelly as Chief Financial Officer,https://www.benzinga.com/pressreleases/20/10/g17789222/supernus-pharmaceuticals-appoints-james-kelly-as-chief-financial-officer,https://j.mp/36zgIAd
Benzinga,"Brookline Bancorp, Inc. Announces Third Quarter 2020 Earnings Release Date and Conference Call",https://www.benzinga.com/pressreleases/20/10/g17789219/brookline-bancorp-inc-announces-third-quarter-2020-earnings-release-date-and-conference-call,https://j.mp/3jMqQtn
Benzinga,Inventiva selected to present the results of its NATIVE Phase IIb clinical trial with lanifibranor in NASH during a plenary session at The Liver Meeting Digital Experienceâ„¢ 2020,https://www.benzinga.com/pressreleases/20/10/g17789201/inventiva-selected-to-present-the-results-of-its-native-phase-iib-clinical-trial-with-lanifibranor,https://j.mp/3jAe294
Benzinga,Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4),https://www.benzinga.com/pressreleases/20/10/g17789223/cytokinetics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4,https://j.mp/33AeChL
